GOLD stage III-IV patients with COPD had higher ADAM15 mRNA levels in whole lung samples than non-smokers, smokers, and GOLD stage I-II patients with COPD (Fig. 1a). Here, ADAM15 is linked to chronic obstructive pulmonary disease.